The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
Lilly(Eli) & Co (NYSE: LLY) closed the day trading at $640.86 down -14.14% from the previous closing price of $746.37. In other words, the price has decreased by -$14.14 from its previous closing price. On the day, 26.02 million shares were traded. LLY stock price reached its highest trading level at $678.2868 during the session, while it also had its lowest trading level at $633.2.
Ratios:
For a better understanding of LLY, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 188.58 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 162.55. For the most recent quarter (mrq), Quick Ratio is recorded 1.06 and its Current Ratio is at 1.37. In the meantime, Its Debt-to-Equity ratio is 2.44 whereas as Long-Term Debt/Eq ratio is at 2.19.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 24 ’25 when LILLY ENDOWMENT INC sold 280,000 shares for $805.07 per share. The transaction valued at 225,419,259 led to the insider holds 95,736,978 shares of the business.
LILLY ENDOWMENT INC bought 280,000 shares of LLY for $223,689,200 on Jul 24 ’25. On May 27 ’25, another insider, Zakrowski Donald A, who serves as the SVP, Finance, & CAO of the company, sold 1,000 shares for $716.41 each. As a result, the insider received 716,410 and left with 4,840 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LLY now has a Market Capitalization of 670044717056 and an Enterprise Value of 705507426304. As of this moment, Lilly(Eli)’s Price-to-Earnings (P/E) ratio for their current fiscal year is 53.09, and their Forward P/E ratio for the next fiscal year is 21.31. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.26. For the stock, the TTM Price-to-Sale (P/S) ratio is 12.39 while its Price-to-Book (P/B) ratio in mrq is 38.54. Its current Enterprise Value per Revenue stands at 14.397 whereas that against EBITDA is 32.064.
Stock Price History:
The Beta on a monthly basis for LLY is 0.47, which has changed by -0.28128928 over the last 52 weeks, in comparison to a change of 0.18634176 over the same period for the S&P500. Over the past 52 weeks, LLY has reached a high of $972.53, while it has fallen to a 52-week low of $677.09. The 50-Day Moving Average of the stock is -17.20%, while the 200-Day Moving Average is calculated to be -19.97%.
Shares Statistics:
Over the past 3-months, LLY traded about 3.69M shares per day on average, while over the past 10 days, LLY traded about 6545640 shares per day. A total of 947.74M shares are outstanding, with a floating share count of 849.89M. Insiders hold about 10.32% of the company’s shares, while institutions hold 73.64% stake in the company. Shares short for LLY as of 1752537600 were 7643653 with a Short Ratio of 2.07, compared to 1749772800 on 8016527. Therefore, it implies a Short% of Shares Outstanding of 7643653 and a Short% of Float of 0.9599999499999999.
Dividends & Splits
LLY’s forward annual dividend rate is 5.60, up from 0.0 a year ago. Against a Trailing Annual Dividend Yield of 0.0The stock’s 5-year Average Dividend Yield is 1.08. The current Payout Ratio is 44.39% for LLY, which recently paid a dividend on 2025-05-16 with an ex-dividend date of 2025-08-15. Stock splits for the company last occurred on 1997-10-16 when the company split stock in a 2:1 ratio.
Earnings Estimates
The stock of Lilly(Eli) & Co (LLY) is currently in the spotlight, with 12.0 analysts actively rating and assessing its market standing.The consensus estimate for the next quarter is $6.93, with high estimates of $7.63 and low estimates of $6.27.
Analysts are recommending an EPS of between $23.94 and $21.76 for the fiscal current year, implying an average EPS of $22.4. EPS for the following year is $30.16, with 26.0 analysts recommending between $35.9 and $25.42.
Revenue Estimates
11 analysts predict $15.77B in revenue for the current quarter. It ranges from a high estimate of $16.11B to a low estimate of $15.45B. As of the current estimate, Lilly(Eli) & Co’s year-ago sales were $11.44BFor the next quarter, 11 analysts are estimating revenue of $17.4B. There is a high estimate of $18.31B for the next quarter, whereas the lowest estimate is $16.68B.
A total of 18 analysts have provided revenue estimates for LLY’s current fiscal year. The highest revenue estimate was $62.29B, while the lowest revenue estimate was $60B, resulting in an average revenue estimate of $60.82B. In the same quarter a year ago, actual revenue was $45.04BBased on 26 analysts’ estimates, the company’s revenue will be $72.33B in the next fiscal year. The high estimate is $79.1B and the low estimate is $65.07B.
